Ryvu Therapeutics S.A. (RVU)
Market Closed
15 Oct, 02:50 PM
WSE 
zł
17. 44
+0.54
+3.1953%
zł
1.21B Market Cap
- P/E Ratio
- Div Yield
28,966 Volume
0 Eps
zł 16.9
Previous Close Want to track RVU and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | 0.19 |
| | | - | - |
| | | - | - |
| | | - | 0.1 |
| | | - | 0.12 |
| | | - | 0.16 |
| | | - | 0.1 |
| | | - | 0.21 |
| | | - | 0.16 |
| | | - | 0.14 |
RVU Earnings Reports FAQ
What is the earnings per share (EPS) for RVU?
The current EPS is 0.
What is the company's earnings growth rate?
Over the past 9 years, the earnings growth rate has been approximately 16.1%, reflecting the RVU's performance and WSE market conditions.
When is the next earnings release date?
Ryvu Therapeutics S.A has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Ryvu Therapeutics S.A are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for RVU at this time, as Ryvu Therapeutics S.A has no recent EPS data to calculate it.
2026 © Marketlog. All Rights Reserved.
